The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session

scientific article

The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1035101032
P356DOI10.1186/1758-5996-2-69
P932PMC publication ID3020162
P698PubMed publication ID21159194
P5875ResearchGate publication ID49684301

P2093author name stringPablo J Aschner
P2860cites workSaxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trialQ42905727
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P921main subjecttype 2 diabetesQ3025883
P304page(s)69
P577publication date2010-12-15
P1433published inDiabetology and Metabolic SyndromeQ15816649
P1476titleThe role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session
P478volume2

Reverse relations

cites work (P2860)
Q33896433Pramlintide and the treatment of diabetes: a review of the data since its introduction
Q35411329Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

Search more.